捷順科技(002609.SZ):擬使用不超5億元閒置自有資金購買中低風險理財
格隆匯 9 月 18日丨捷順科技(002609.SZ)公佈,公司於2020年9月17日召開了第五屆董事會第十次會議、第五屆監事會第十次會議,會議分別審議通過了《關於使用部分閒置自有資金進行委託理財的議案》,同意公司(含控股子公司)在確保不影響正常運營和資金安全的前提下,擬使用不超過人民幣5億元(含)的閒置自有資金購買中低風險理財(產品期限不超過24個月(含)),上述額度自股東大會審議通過之日起12個月內有效,在前述額度和期限範圍內,可循環滾動使用。公司董事會提請股東大會授權公司經營管理層行使投資決策權並簽署相關文件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.